Not antagonist treatment.
Year: 2014
Type: article
Abstract: Regarding the article “Safety of the newer class of opioid antagonists in pregnancy,”[1][1] the title of the article notwithstanding, its focus—the buprenorphinenaloxone combination—is not antagonist treatment. Rather, it is treatment with an opioid—buprenorphine—that has both agonist
Source: Europe PMC (PubMed Central)
Authors: Robert Newman, Susan Gevertz
Language: French
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1497956626
